Kind Pharmaceutical
Latest round
- Series C
Last raised
- Nov 2025
Total raised
- $85M
Investors
- 13
About Kind Pharmaceutical
Established in 2014 and headquartered in Hangzhou, China, Kind Pharmaceutical LLC is a multinational pharmaceutical company engaged in the research and development of innovative therapeutics.S. research facility located at the Pharmaceutical Research Center in San Francisco and a China site in the Community of Industries in Zhejiang Province. The company's products include AND17, AND19, Antibody-drug conjugates (ADCs), and AND021. AND017 is a small molecular inhibitor of prolyl hydroxylase, mimics the natural physiological regulation under hypoxia condition to stabilize HIF and promote the production of red blood cells to treat anemia. AND019 is a novel third generation selective estrogen receptor degrader, which is a competitive antagonist of estrogen receptor (ER) by binding with ER to mediate its degradation. AND021 program is currently under clinical candidate nomination step. It will be developed for HIF-2-dependent renal cell carcinoma and other difficult-to-treat diseases. The company primarily generates revenue through research collaborations, licensing agreements and payments related to its drug discovery and development programs.
Who invested in Kind Pharmaceutical
13 investors across 3 rounds
See all investors in Kind Pharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kind Pharmaceutical
Who invested in Kind Pharmaceutical?
Kind Pharmaceutical has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kind Pharmaceutical raised?
Kind Pharmaceutical has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Kind Pharmaceutical last raise money?
Kind Pharmaceutical's most recent round on record is a Series C, in Nov 2025.
What does Kind Pharmaceutical do?
Established in 2014 and headquartered in Hangzhou, China, Kind Pharmaceutical LLC is a multinational pharmaceutical company engaged in the research and development of innovative therapeutics.
Where is Kind Pharmaceutical headquartered?
Kind Pharmaceutical is headquartered in Hangzhou, China.
Which VCs invest in companies like Kind Pharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Kind Pharmaceutical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Kind Pharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.